Insights

Global Clinical Expertise OPIS boasts over 26 years of experience managing more than 1500 clinical trials across numerous therapeutic areas on an international scale, positioning it as a reliable partner for pharmaceutical, biotech, and medical device companies seeking comprehensive trial support worldwide.

Expansion Potential With affiliates in 18 countries and continuous growth ambitions, OPIS offers opportunities for partners to collaborate on cross-border clinical projects, particularly in emerging markets requiring specialized clinical research capabilities.

Regulatory and Scientific Strength OPIS’s expertise in navigating local regulatory landscapes combined with its medical and scientific consultancy services presents a valuable partnership avenue for organizations seeking smooth global trial execution and compliance.

Technology and Data Security The company's investment in digital tools and its recent partnership with DPO International demonstrate a focus on data privacy and security, opening doors for clients prioritizing secure clinical data management and compliance with data protection standards.

Diverse Therapeutic Focus Working across a broad spectrum of therapeutic areas from oncology to rare diseases, OPIS can support a wide range of clinical programs, making it a versatile partner for companies exploring new fields or expanding their clinical research portfolios.

OPIS Tech Stack

OPIS uses 8 technology products and services including Open Graph, RSS, oEmbed, and more. Explore OPIS's tech stack below.

  • Open Graph
    Content Management System
  • RSS
    Content Management System
  • oEmbed
    Dev Tools
  • JSON-LD
    Javascript Frameworks
  • Lodash
    Javascript Libraries
  • jQuery Migrate
    Javascript Libraries
  • Adobe Creative Suite
    Visualisation Software
  • Webex
    Web Conferencing

OPIS's Email Address Formats

OPIS uses at least 2 format(s):
OPIS Email FormatsExamplePercentage
First.Last@opis.itJohn.Doe@opis.it
95%
FirLast@opis.itJohDoe@opis.it
2%
LastFir@opis.itDoeJoh@opis.it
2%
LastFi@opis.itDoeJo@opis.it
1%
First.Last@opisresearch.comJohn.Doe@opisresearch.com
96%
First.Middle@opisresearch.comJohn.Michael@opisresearch.com
4%

Frequently Asked Questions

What is OPIS's stock symbol?

Minus sign iconPlus sign icon
OPIS is a publicly traded company; the company's stock symbol is GPBPUSD.

What is OPIS's official website and social media links?

Minus sign iconPlus sign icon
OPIS's official website is opisresearch.com and has social profiles on LinkedIn.

What is OPIS's NAICS code?

Minus sign iconPlus sign icon
OPIS's NAICS code is 5417 - Scientific Research and Development Services.

How many employees does OPIS have currently?

Minus sign iconPlus sign icon
As of December 2025, OPIS has approximately 269 employees across 5 continents, including EuropeNorth AmericaAsia. Key team members include Chief Executive Officer: L. A.Chief Operating Officer: L. H.Chief Operating Officer: N. A.. Explore OPIS's employee directory with LeadIQ.

What industry does OPIS belong to?

Minus sign iconPlus sign icon
OPIS operates in the Research Services industry.

What technology does OPIS use?

Minus sign iconPlus sign icon
OPIS's tech stack includes Open GraphRSSoEmbedJSON-LDLodashjQuery MigrateAdobe Creative SuiteWebex.

What is OPIS's email format?

Minus sign iconPlus sign icon
OPIS's email format typically follows the pattern of First.Last@opis.it. Find more OPIS email formats with LeadIQ.

When was OPIS founded?

Minus sign iconPlus sign icon
OPIS was founded in 1998.

OPIS

Research ServicesLombardy, Italy201-500 Employees

OPIS was founded in 1998 by medical doctors from the Pharma Industry and is a global clinical CRO with 26 years of experience in a wide range of therapeutic areas. OPIS provides full-service, 360° clinical trial support from study concept creation and protocol development to full project execution, study data handling and up to study closure, analysis, and reporting. We manage Phase I-IV, interventional, non-interventional and medical device studies on an international level. In addition, OPIS also manages pre- and post-marketing clinical investigations for medical and diagnostic devices, nutraceuticals, and food supplement studies.

Our qualified, fully trained, and dedicated staff have managed more than 1500 studies.
OPIS’s strength lies in its people and its specialized teams who assist clients from A-Z with medical writing, scientific and statistical consultancy for trial design and skilled teams of operational staff that ensure high-quality project execution, with global coverage.

Our mission is to increase the global development of safe and effective medical therapeutics through its high-science and disciplined operating approach that leverages local regulatory and deep therapeutic expertise across all major areas, including oncology, cardiology, dermatology, endocrinology, gastroenterology, gene therapy, hematology, genetic diseases, hepatology, immunology, infectious diseases, musculoskeletal, dietary supplements, metabolism and nutrition disorders, nephrology, neurology, onco-hematology, ophthalmology, respiratory diseases, rare diseases, urogenital disorders and vaccines.

OPIS is committed to continuous growth and expansion, and currently we have affiliates in 18 countries around the world.

For more information, visit www.opisresearch.com
For Employment and Careers, visit www.opisresearch.com/opis-career/

Section iconCompany Overview

Stock Symbol
GPBPUSD
NAICS Code
5417 - Scientific Research and Development Services
Founded
1998
Employees
201-500

Section iconFunding & Financials

  • $10M$25M

    OPIS's revenue is estimated to be in the range of $10M$25M

Section iconFunding & Financials

  • $10M$25M

    OPIS's revenue is estimated to be in the range of $10M$25M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.